Schizophrenia: evidence brief
Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 (capped at 1,000 of 1,859 matching trials) · https://research.opensourcemed.info/briefs/schizophrenia.html
Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.
Medicines with registered trials
Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.
- Risperidone 6 trials
- Aripiprazole 4 trials
- Olanzapine 4 trials
- Brexpiprazole (OPC-34712) 3 trials
- Alpha Lipoic Acid 2 trials
- Atomoxetine 2 trials
Non-drug approaches tested
Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.
- Transcranial brain stimulation (tDCS, TMS) 108 trials · 37 completed · 18 with results
- Cognitive training and remediation 46 trials · 21 completed · 10 with results
- Cognitive behavioural and related therapies 43 trials · 23 completed · 4 with results
- Psychotherapy, counselling and peer support 42 trials · 21 completed · 3 with results
- Education, coaching and self-management 29 trials · 16 completed · 2 with results
- Care coordination, navigation and outreach 8 trials · 4 completed · 2 with results
Natural products (RepurpOS Moderate tier)
Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.
- N-Acetylcysteine
- Vitamin B12
- Glycine
- Ashwagandha
- L-Theanine
- Chromium
Trials recruiting
Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.
- A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive… NCT07615426
- Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia NCT04959201
- Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia NCT04917302
- Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium:… NCT07900893
- Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization NCT07130500
- Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive… NCT04296604
What we don't know yet
Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.
- Mind-body and psychological approaches: cognition 17 trials, no results posted yet
- Exercise and physical activity: physical function and exercise capacity 10 trials, no results posted yet